There’s a lot of investment capital floating around out there, and the Pharmaceuticals and Life Sciences (PLS) sector could benefit this year. According to a report by international accounting firm PwC, there’s considerable money and investment interest in the space, including over $1.7T in private equity. And this week’s BIO CEO & Investor Conference in New York City reports an increase in investor activity in 2020 and has an impressive guest list. The emergence of a global health crisis in the form of the 2019 novel coronavirus will only accelerate the activity, and the Forbes report on CRISPR company Mammoth Biosciences’ $45M Series B round at the end of January cite the company’s work with partners to develop a rapid diagnostic for the virus. We should ready ourselves for an interesting year.
Reach out to me if you want to know more or discuss your medical product development challenges.
https://calendly.com/katrinarogers
Text Copyright © 2020 Katrina Rogers